[go: up one dir, main page]

GB201911064D0 - Therapy - Google Patents

Therapy

Info

Publication number
GB201911064D0
GB201911064D0 GBGB1911064.2A GB201911064A GB201911064D0 GB 201911064 D0 GB201911064 D0 GB 201911064D0 GB 201911064 A GB201911064 A GB 201911064A GB 201911064 D0 GB201911064 D0 GB 201911064D0
Authority
GB
United Kingdom
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1911064.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tarian Biologics Ltd
Original Assignee
Tarian Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tarian Biologics Ltd filed Critical Tarian Biologics Ltd
Priority to GBGB1911064.2A priority Critical patent/GB201911064D0/en
Publication of GB201911064D0 publication Critical patent/GB201911064D0/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
GBGB1911064.2A 2019-08-02 2019-08-02 Therapy Ceased GB201911064D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1911064.2A GB201911064D0 (en) 2019-08-02 2019-08-02 Therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1911064.2A GB201911064D0 (en) 2019-08-02 2019-08-02 Therapy

Publications (1)

Publication Number Publication Date
GB201911064D0 true GB201911064D0 (en) 2019-09-18

Family

ID=67957170

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1911064.2A Ceased GB201911064D0 (en) 2019-08-02 2019-08-02 Therapy

Country Status (1)

Country Link
GB (1) GB201911064D0 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006204A1 (en) 1990-09-28 1992-04-16 Ixsys, Inc. Surface expression libraries of heteromeric receptors
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO2003064472A2 (en) 2002-01-28 2003-08-07 Aimsco Limited Treatment of ms with goat serum
WO2006021814A2 (en) 2004-07-08 2006-03-02 Aimsco Limited Medicament
WO2014001749A1 (en) 2012-06-25 2014-01-03 Aimsco Limited Formulation comprising crh and alpha - 2 - immunoglobulin
WO2015097460A1 (en) 2013-12-23 2015-07-02 Aimsco Limited Improved formulation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1992006204A1 (en) 1990-09-28 1992-04-16 Ixsys, Inc. Surface expression libraries of heteromeric receptors
WO2003064472A2 (en) 2002-01-28 2003-08-07 Aimsco Limited Treatment of ms with goat serum
WO2006021814A2 (en) 2004-07-08 2006-03-02 Aimsco Limited Medicament
WO2014001749A1 (en) 2012-06-25 2014-01-03 Aimsco Limited Formulation comprising crh and alpha - 2 - immunoglobulin
WO2015097460A1 (en) 2013-12-23 2015-07-02 Aimsco Limited Improved formulation

Non-Patent Citations (36)

* Cited by examiner, † Cited by third party
Title
"GenBank", Database accession no. NM 001081343.1
"UniProt", Database accession no. Q96LT7
ALTSCHUL ET AL., BULL. MATH. BIO., vol. 48, 1986, pages 603 - 16
BOWIESAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 6
BURBERRY ET AL., SCI TRANSL MED, vol. 8, no. 347, 2016, pages 347ra93
C. E. LAWRENCE ET AL.: "Detecting Subtle Sequence Signals: A Gibbs Sampling Strategy for Multiple Alignment", SCIENCE, vol. 262, no. 5131, 1993, pages 208 - 214, XP001152872, doi:10.1126/science.8211139
CHUNG ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 10145 - 9
CHUNG ET AL., SCIENCE, vol. 259, 1993, pages 806 - 9
CUNNINGHAMWELLS, SCIENCE, vol. 244, 1989, pages 1081 - 5
DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 12
DEJESUS-HERNANDEZ ET AL., NEURON, vol. 72, 2011, pages 257 - 268
DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145
ELLMAN ET AL., METHODS ENZYMOL., vol. 202, 1991, pages 301
ERIC DEPIEREUXERNEST FEYTMANS: "Match-Box: A Fundamentally New Algorithm for the Simultaneous Alignment of Several Protein Sequences", CABIOS, vol. 8, no. 5, 1992, pages 501 - 509
FRICK ET AL., ACTA NEUROPATHOLOGICA COMMUNICATIONS, vol. 6, 2018, pages 18
GURNEY, SCIENCE, vol. 264, no. 5166, 17 June 1994 (1994-06-17), pages 1772 - 5
HALEMARHAM: "THE HARPER COLLINS DICTIONARY OF BIOLOGY", 1991, HARPER PERENNIAL
HENIKOFFHENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 19
IVO VAN WALLE ET AL.: "Align-M - A New Algorithm for Multiple Alignment of Highly Divergent Sequences", BIOINFORMATICS, vol. 20, no. 9, 2004, pages 1428 - 1435
JULIE D. THOMPSON ET AL.: "CLUSTAL W: Improving the Sensitivity of Progressive Multiple Sequence Alignment Through Sequence Weighting, Position- Specific Gap Penalties and Weight Matrix Choice", NUCLEIC ACIDS RESEARCH, vol. 22, no. 22, 1994, pages 4673 - 4680, XP002956304
K.G. HOOTEN ET AL., NEUROTHERAPEUTICS, vol. 12, 2015, pages 364 - 375
KOIDE ET AL., BIOCHEM., vol. 33, 1994, pages 7470 - 6
LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 7
NER ET AL., DNA, vol. 7, 1988, pages 127
O'ROURKE ET AL., SCIENCE, vol. 351, no. 6279, 2016, pages 1324 - 1329
OSAMU GOTOH: "Significant Improvement in Accuracy of Multiple Protein. Sequence Alignments by Iterative Refinement as Assessed by Reference to Structural Alignments", J. MOL. BIOL., vol. 264, no. 4, 1996, pages 823 - 838
REIDHAAR-OLSONSAUER, SCIENCE, vol. 241, 1988, pages 53 - 7
ROBERTSON ET AL., J. AM. CHEM. SOC., vol. 113, 1991, pages 2722
SINGLETON ET AL.: "DICTIONARY OF MICROBIOLOGY AND MOLECULAR BIOLOGY", 1994, JOHN WILEY AND SONS
SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904
TURCATTI ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 19991 - 8
VAN BLITTERSWIJK, ACTA NEUROPATHOL, vol. 130, 2015, pages 863 - 876
WAITE ET AL., NEUROBIOL AGING, vol. 35, 2014, pages 1779 e1775 - 1779
WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64
WYNNRICHARDS, PROTEIN SCI., vol. 2, 1993, pages 395 - 403
XU ET AL., PLOS ONE, vol. 10, no. 12, 2015, pages e0145347

Similar Documents

Publication Publication Date Title
IL277336A (en) Combination therapy
GB201804255D0 (en) Macrophage-based therapy
GB201900702D0 (en) Therapy
GB201819853D0 (en) Therapy
ZA202200731B (en) Combination therapy
IL280729A (en) Combination therapy
IL279908A (en) Combination therapy
IL288237A (en) Combination therapy
GB201918752D0 (en) New therapy
GB201912191D0 (en) New therapy
GB201914006D0 (en) Combination Therapy
GB201910473D0 (en) Combination therapy
GB201906864D0 (en) Combination therapy
GB201817385D0 (en) Therapy
GB201818579D0 (en) New therapy
GB201814036D0 (en) New therapy
GB201919036D0 (en) Therapy
GB201916983D0 (en) Therapy
GB201914848D0 (en) Therapy
GB201913797D0 (en) Therapy
GB201913785D0 (en) Therapy
GB201912524D0 (en) Therapy
GB201911948D0 (en) Therapy
GB201911064D0 (en) Therapy
GB201919301D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)